Company / Current Liabilities
CRESCENT BIOPHARMA, INC. Current Liabilities History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$36.1M
FY2025
5-year range
$6.3M / $36.1M
FY2021-FY2025
Trend
+341.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities changed +341% YoY in FY2025, a notable deviation from the 4-year average annual change of +93%.
Based on SEC 10-K filings.
$36M in FY2025 with a 10-year CAGR of +16.6%.
Increased from $6M to $36M over the past 9 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +16.6%
Key checks
Key Insights
- In FY2025, current liabilities increased 341.3% year-over-year.
- Lowest current liabilities in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $36.1M | +341.3% |
| FY2017 | $8.2M | +29.1% |
| FY2016 | $6.3M | -18.2% |
| FY2015 | $7.7M | +19.9% |
| FY2014 | $6.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026